Acute Effects of Warm Whirlpool Bath Therapy on Forearm and Hand Muscle Stiffness and Pain in Carpal Tunnel Syndrome
CTS-WB
1 other identifier
interventional
24
1 country
1
Brief Summary
Carpal tunnel syndrome (CTS) is a common entrapment neuropathy that causes pain, paresthesia and functional limitations in the hand and wrist. Hydrotherapy methods such as warm whirlpool baths are frequently used in physiotherapy practice to reduce pain and improve soft-tissue properties, but their acute effects on forearm and hand muscle stiffness in CTS have not been clearly quantified. This randomized controlled trial aims to investigate the acute effects of a single session of warm whirlpool bath therapy on forearm and hand muscle stiffness and pain intensity in adults with CTS. Participants diagnosed with CTS will be randomly allocated to an experimental group receiving a 20-minute warm whirlpool bath or to a resting control group. Muscle stiffness of selected forearm and hand muscles will be assessed using the MyotonPRO device, and pain intensity will be recorded with a numeric rating scale, immediately before and after the intervention. It is hypothesized that warm whirlpool bath therapy will produce a greater reduction in muscle stiffness and pain compared with rest alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
November 28, 2025
CompletedStudy Start
First participant enrolled
November 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2025
CompletedNovember 28, 2025
November 1, 2025
10 days
November 19, 2025
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary
Dynamic muscle stiffness (N/m) of selected muscles on the affected upper limb (abductor pollicis brevis, flexor digitorum superficialis, extensor carpi radialis brevis, flexor carpi ulnaris) measured with the MyotonPRO device. For each muscle, three consecutive measurements will be recorded and the mean value will be used for analysis. The primary outcome is the change in stiffness from baseline to post-intervention, compared between the warm whirlpool bath group and the resting control group. Higher values indicate greater muscle stiffness.
Baseline (pre-intervention) and immediately after the single 20-minute session (within approximately 5 minutes)
Secondary Outcomes (1)
Change in Pain Intensity in the Affected Hand/Wrist
Baseline (pre-intervention) and immediately after the single 20-minute session (within approximately 5 minutes)
Study Arms (2)
Warm Whirlpool Bath Therapy
EXPERIMENTALParticipants receive a single session of warm whirlpool bath therapy applied to the affected forearm and hand for 20 minutes.
Resting Control
ACTIVE COMPARATORParticipants rest in a comfortable supported position for 20 minutes without whirlpool or thermal intervention.
Interventions
The affected hand and forearm are immersed in a therapeutic whirlpool bath with gently circulating water at approximately 38-39°C for 20 minutes. Participants are positioned to ensure comfort and muscle relaxation. Skin integrity and tolerance to heat are checked before treatment and monitored throughout the session
Participants rest in a comfortable supine or seated position with the affected forearm supported for 20 minutes. No active hydrotherapy, thermal or manual intervention is applied. Positioning and monitoring are comparable to the experimental group.
Eligibility Criteria
You may qualify if:
- Being apparently healthy without a known chronic systemic disease
- Physically active participants, regardless of gender
- Adults aged 18-65 years diagnosed with carpal tunnel syndrome
- No history of other chronic musculoskeletal or neurological disorders
- Not having any acute upper limb injury
You may not qualify if:
- Having a previous surgery on the affected wrist or hand
- Systemic conditions affecting nerve function, such as diabetes mellitus or thyroid disease
- Having a cardiovascular disease or uncontrolled hypertension
- Being younger than 18 or older than 65 years
- Being pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Erzurum Technical Universitylead
- Amasya Universitycollaborator
- Bangor Universitycollaborator
Study Sites (1)
Erzurum Şehir Hastanesi
Erzurum, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gökhan YAĞIZ
Amasya University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention, neither participants nor treating therapists are blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
November 19, 2025
First Posted
November 28, 2025
Study Start
November 30, 2025
Primary Completion
December 10, 2025
Study Completion
December 10, 2025
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared. This is a single-center study with a relatively small sample size and a specific clinical population, which increases the risk of indirect re-identification even after de-identification. In addition, the current ethical approval and informed consent procedures do not explicitly cover external data sharing, and the study team has limited resources to support and monitor secondary data use. Aggregate results (e.g., group means and standard deviations) will be reported in scientific publications and presentations.